First-in-human Study of 7MW4911 in Patients With Advanced Solid Tumors

NCT07265622 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

200

Enrollment

INDUSTRY

Sponsor class

Conditions

Solid Tumors

Interventions

DRUG: 7MW4911

Sponsor

Mabwell (Shanghai) Bioscience Co., Ltd.